Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1240947

First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia

Rnjak, Dina; Štajduhar, Anamarija; Popović-Grle, Sanja; Ferara, Nikola; Jelavić, Iva; Lampalo, Marina
First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia // European respiratory society international congress 2022
Barcelona, Španjolska, 2022. str. 1-1 (poster, podatak o recenziji nije dostupan, sažetak, znanstveni)

CROSBI ID: 1240947 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia

Autori
Rnjak, Dina ; Štajduhar, Anamarija ; Popović-Grle, Sanja ; Ferara, Nikola ; Jelavić, Iva ; Lampalo, Marina

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Skup
European respiratory society international congress 2022

Mjesto i datum
Barcelona, Španjolska, 04.-06.09.2022

Vrsta sudjelovanja
Poster

Vrsta recenzije
Podatak o recenziji nije dostupan

Ključne riječi
Anti-IL5 ; Severe asthma

Sažetak
Currently in Croatia, there are 275 severe asthma patients treated with biological therapy. Most of them (201) are receiving anti-IL5 therapy. To assess the outcomes of the most used biological therapy in severe asthma patients in Croatia, we conducted a real-life study, including 41 patients receiving anti-IL5 therapy at Clinical Center for Lung Diseases Jordanovac. Although our data offers some insight into biological therapeutics outcomes, we need a larger group of patients to make more precise conclusions.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita



POVEZANOST RADA

Ustanove:
Klinika za plućne bolesti "Jordanovac"

Profili:

Avatar Url Iva Jelavic (autor)

Avatar Url Nikola Ferara (autor)

Avatar Url Marina Lampalo (autor)

Avatar Url Sanja Popović-Grle (autor)

Poveznice na cjeloviti tekst rada:

s3.eu-central-1.amazonaws.com s3.eu-central-1.amazonaws.com

Citiraj ovu publikaciju:

Rnjak, Dina; Štajduhar, Anamarija; Popović-Grle, Sanja; Ferara, Nikola; Jelavić, Iva; Lampalo, Marina
First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia // European respiratory society international congress 2022
Barcelona, Španjolska, 2022. str. 1-1 (poster, podatak o recenziji nije dostupan, sažetak, znanstveni)
Rnjak, D., Štajduhar, A., Popović-Grle, S., Ferara, N., Jelavić, I. & Lampalo, M. (2022) First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia. U: European respiratory society international congress 2022.
@article{article, author = {Rnjak, Dina and \v{S}tajduhar, Anamarija and Popovi\'{c}-Grle, Sanja and Ferara, Nikola and Jelavi\'{c}, Iva and Lampalo, Marina}, year = {2022}, pages = {1-1}, keywords = {Anti-IL5, Severe asthma}, title = {First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia}, keyword = {Anti-IL5, Severe asthma}, publisherplace = {Barcelona, \v{S}panjolska} }
@article{article, author = {Rnjak, Dina and \v{S}tajduhar, Anamarija and Popovi\'{c}-Grle, Sanja and Ferara, Nikola and Jelavi\'{c}, Iva and Lampalo, Marina}, year = {2022}, pages = {1-1}, keywords = {Anti-IL5, Severe asthma}, title = {First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia}, keyword = {Anti-IL5, Severe asthma}, publisherplace = {Barcelona, \v{S}panjolska} }

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.